| Class Number |
Class Name |
Patents |
| 514/ |
Dermatitis |
0 |
| 514/ |
Mouth treatment |
0 |
| 514/ |
Liquid carrier, diluent or solvent |
0 |
| 514/ |
Solid carrier or solid diluent |
0 |
| 514/ |
Gaseous or gas emitting carrier or propellant |
0 |
| 514/ |
Pill, lozenge, tablet or capsule |
0 |
| 514/ |
Suppository, bougie or base |
0 |
| 514/ |
Special designated ingredient |
0 |
| 514/ |
Designated organic active ingredient containing (doai) |
0 |
| 514/1 |
Designated organic active ingredient containing (doai) |
370 |
| 514/769 |
Designated inorganic nonactive ingredient or elemental material other than water |
148 |
| 514/772 |
Designated organic nonactive ingredient containing other than hydrocarbon |
642 |
| 514/788.1 |
Solid synthetic organic polymer derived solely from hydrocarbon reactants as designated organic nonactive ingredient containing |
29 |
| 514/789 |
Miscellaneous (e.g., hydrocarbons, etc.) |
167 |
| 514/800 |
Lhrh like |
202 |
| 514/801 |
Collagen, gelatin or derivatives thereof |
199 |
| 514/802 |
Fibrinopeptides, blood-coagulation factors or derivatives |
115 |
| 514/803 |
Kinin or derivatives |
12 |
| 514/804 |
Phecmycin series or derivatives |
4 |
| 514/805 |
Adrenocorticotropic hormone or derivatives |
32 |
| 514/806 |
Somatostatin or derivatives |
125 |
| 514/807 |
Oxytoxin, vasopressin or derivatives |
60 |
| 514/808 |
Calcitonin or derivatives |
61 |
| 514/809 |
Enkephalin or endorphin or derivatives |
139 |
| 514/810 |
Addiction |
99 |
| 514/814 |
Anemia |
109 |
| 514/816 |
Anesthetic, general |
95 |
| 514/817 |
Anesthetic, topical |
138 |
| 514/818 |
Anesthetic, local |
109 |
| 514/819 |
Antacid, oral |
84 |
| 514/821 |
Antiarrhythmic |
423 |
| 514/822 |
Anticoagulation |
469 |
| 514/823 |
Antidote |
85 |
| 514/824 |
Arteriosclerosis |
610 |
| 514/825 |
Arthritis |
683 |
| 514/826 |
Asthma |
811 |
| 514/827 |
Astringent, nonfacial |
24 |
| 514/829 |
Bite or sting |
41 |
| 514/832 |
Blood substitute |
174 |
| 514/833 |
Blood plasma extender |
87 |
| 514/834 |
Coagulant |
73 |
| 514/835 |
Caries |
95 |
| 514/836 |
Chelate |
224 |
| 514/837 |
Cholera |
18 |
| 514/838 |
Cirrhosis |
34 |
| 514/839 |
Contact lens treatment |
119 |
| 514/841 |
Contraceptive |
138 |
| 514/844 |
Cosmetic, facial |
1,370 |
| 514/849 |
Cough and cold preparation |
119 |
| 514/851 |
Cystic fibrosis |
114 |
| 514/852 |
Dandruff |
113 |
| 514/853 |
Decongestant |
62 |
| 514/866 |
Diabetes |
905 |
| 514/867 |
Diarrhea |
199 |
| 514/868 |
Distemper |
5 |
| 514/869 |
Diuretic |
276 |
| 514/870 |
Edema |
136 |
| 514/872 |
Emesis (motion sickness-nausea) |
105 |
| 514/873 |
Emollient |
257 |
| 514/874 |
Estrogenic agent (noncontraceptive) |
63 |
| 514/875 |
Flea control |
45 |
| 514/877 |
Gallstone |
30 |
| 514/878 |
Geriatrics |
59 |
| 514/880 |
Hair treatment (therapeutic-scalp) |
442 |
| 514/882 |
Hemorrhoid preparation |
67 |
| 514/883 |
Hodgkin's disease |
26 |
| 514/884 |
Hypoglycemia |
69 |
| 514/885 |
Immune response affecting drug |
1,090 |
| 514/886 |
Inflammation, skin |
514 |
| 514/888 |
Influenza |
70 |
| 514/889 |
Interferon inducer |
112 |
| 514/890 |
Irritant (e.g., tear gas, etc.) |
7 |
| 514/891 |
Kidney stone |
50 |
| 514/892 |
Laxative |
85 |
| 514/893 |
Liver disorder |
154 |
| 514/895 |
Malaria |
92 |
| 514/896 |
Measles |
11 |
| 514/898 |
Meningitis |
14 |
| 514/899 |
Menstrual disorder |
105 |
| 514/903 |
Multiple sclerosis |
159 |
| 514/904 |
Multiple vitamins |
108 |
| 514/906 |
Muscle relaxant |
204 |
| 514/907 |
Muscular dystrophy |
26 |
| 514/908 |
Leukemia |
335 |
| 514/909 |
Obesity |
265 |
| 514/912 |
Ophthalmic |
939 |
| 514/916 |
Pyretic |
137 |
| 514/917 |
Radioactive, anti- |
34 |
| 514/918 |
Repellent |
73 |
| 514/921 |
Shock |
135 |
| 514/922 |
Side effect reduction by incorporation of a second designated ingredient |
239 |
| 514/923 |
Sleep aid (insomnia) |
83 |
| 514/924 |
Tuberculosis |
47 |
| 514/925 |
Ulcer treatment |
343 |
| 514/929 |
Vasodilator |
410 |
| 514/930 |
Vasoconstrictor (nondecongestant) |
57 |
| 514/931 |
Veneral disease |
78 |
| 514/935 |
Uterine motility |
41 |
| 514/936 |
Dmso containing |
59 |
| 514/937 |
Dispersion or emulsion |
1,302 |
| 514/944 |
Gel |
1,147 |
| 514/945 |
Foam |
196 |
| 514/946 |
Penetrant or absorbent (enhances penetration into subject treated) |
386 |
| 514/948 |
Solid candy type |
78 |
| 514/949 |
Naturally derived clay (e.g., bentonite, etc.) |
75 |
| 514/950 |
Macromolecular (other than synthetic resins) |
42 |
| 514/951 |
Powders, granules or particles of specified mesh or particle size |
470 |
| 514/953 |
Shaped forms adapted for noningestible use other than suppository type (e.g., films, inserts, etc.) |
163 |
| 514/957 |
Vapor emmitting composition |
77 |
| 514/958 |
For smoking or inhaling |
175 |
| 514/959 |
Breathing gases |
49 |
| 514/960 |
Significant, tablet formulation (e.g., designated excipient, disintegrant, glydent or lubricant, etc.) |
447 |
| 514/962 |
Capsule (e.g., gelatin, etc.) |
307 |
| 514/964 |
Sustained or differential release type |
312 |
| 514/966 |
Rectal |
144 |
| 514/967 |
Vaginal |
166 |
| 514/968 |
Urethral |
42 |
| 514/969 |
Ointment or salve base |
362 |
| 514/970 |
Containing designated ingredient to stabilize an active ingredient |
491 |
| 514/974 |
Containing designated ingredient to reduce noxious effects of active ingredient (e.g., taste masking, odor reducing, etc.) |
254 |
| 514/975 |
Characterized by the designated surfactant used |
358 |
